According to BioIntel360, Latin America gene editing technology market size is expected to record a CAGR of 7.7% during 2023-2027 to reach US$467.6 million by 2027, increasing from US$323.0 million in...
According to BioIntel360, Latin America gene editing technology market size is expected to record a CAGR of 7.7% during 2023-2027 to reach US$467.6 million by 2027, increasing from US$323.0 million in 2023. Over the last five years, the sector has recorded a CAGR of 9.0% to reach US$296.2 million in 2022. This offering from BioIntel360 is a bundled offering, combining 4 countries and a key report covering Latin America region. This report provides an in-depth data-centric analysis of the emerging opportunities in the gene editing industry. It covers a detailed view of market size and forecast across various segments such as gene editing technologies (CRISPR, meganucleases, TALEN, and ZFN), by products, delivery method, disease/disorders, and application. This title from BioIntel360 is a bundled offering, combining the following 5 reports, covering 175+ tables and 220+ figures: Country Report 1- Latin America Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2- Brazil Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 - Argentina Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4- Colombia Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 5- Mexico Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update
This report provides an in-depth, data-centric analysis of the Latin America's gene editing market 2018-2027. Below is a summary of key market segments: By Technology • CRISPR CAS 9 • TALENs • ZFN • Others (Meganucleases) By CRISPR PRODUCTS • Kits & Enzymes • Cell lines & Antibodies • Others (Plasmid, Controls) By TALENs PRODUCTS • Kits & Enzymes • Cell lines & Antibodies • Others (Plasmid, Controls) By ZFNs PRODUCTS • Kits & Enzymes • Cell lines & Antibodies • Others (Plasmid, Controls) By Meganucleases PRODUCTS • Kits & Enzymes • Cell lines & Antibodies • Others (Plasmid, Controls) By Delivery Method • Ex-vivo • In-vivo By Disease/Disorders • Cancer • Blood Disorders (beta-thalassemia and sickle cell disease) • Blindness • Respiratory Disease (COVID-19 & Cystic fibrosis) • Others (AIDS, Huntington’s disease, Muscular dystrophy) By Application • Drug Development • Diagnostics • Plant Gene Editing • Others (Animal Gene Editing) By End-User • Pharmaceutical and Biopharmaceutical Companies • Biotechnology Companies • Contract Research Organisations • Academic Institutes and Research Centres
• In-depth understanding of gene editing market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in Latin America. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and contract research organisations.
This title from BioIntel360 is a bundled offering, combining the following 5 reports, covering 175+ tables and 220+ figures: Country Report 1- Latin America Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2- Brazil Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 - Argentina Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4- Colombia Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update Country Report 5- Mexico Gene Editing Technology Business and Investment Opportunities Databook – Q2 2023 Update 1 About this report 1.1 Research Methodology 1.2 Disclaimer 2 Gene Editing Technology Market Size and Forecast, 2018-2027 3 Gene Editing Technology Market Size by Technology, 2018-2027 3.1 Gene Editing Technology Market Share by Technology (%), 2018-2027 3.2 Gene Editing Technology Market Size and Forecast by CRISPR, 2018-2027 3.3 Gene Editing Technology Market Size and Forecast by TALENs, 2018-2027 3.4 Gene Editing Technology Market Size and Forecast by ZFNs, 2018-2027 3.5 Gene Editing Technology Market Size and Forecast by Meganucleases, 2018-2027 4 Gene Editing Technology Market Size by CRISPR Product, 2018-2027 4.1 Gene Editing Technology Market Share by CRISPR Product (%), 2018-2027 4.2 Gene Editing Technology Market Size and Forecast by Vector Based Cas9, 2018-2027 4.3 Gene Editing Technology Market Size and Forecast by DNA Free Cas9, 2018-2027 4.4 Gene Editing Technology Market Size and Forecast by Libraries & Antibodies, 2018-2027 4.5 Gene Editing Technology Market Size and Forecast by gRNA Design and Vector Construction, 2018-2027 4.6 Gene Editing Technology Market Size and Forecast by Cell Lines & Engineering, 2018-2027 4.7 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027 5 Gene Editing Technology Market Size by TALENs Product, 2018-2027 5.1 Gene Editing Technology Market Share by TALENs Product (%), 2018-2027 5.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027 5.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027 5.4 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027 6 Gene Editing Technology Market Size by ZFNs Product, 2018-2027 6.1 Gene Editing Technology Market Share by ZFNs Product (%), 2018-2027 6.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027 6.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027 6.4 Gene Editing Technology Market Size and Forecast by Others 7 Gene Editing Technology Market Size by Meganucleases Product, 2018-2027 7.1 Gene Editing Technology Market Share by Meganucleases Product (%), 2018-2027 7.2 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027 7.3 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027 7.4 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027 8 Gene Editing Technology Market Size by Delivery Mode, 2018-2027 8.1 Gene Editing Technology Market Share by Delivery Mode (%), 2018-2027 8.2 Gene Editing Technology Market Size and Forecast by Ex-vivo, 2018-2027 8.3 Gene Editing Technology Market Size and Forecast by In-vivo, 2018-2027 9 Gene Editing Technology Market Size by Diseases/Disorders, 2018-2027 9.1 Gene Editing Technology Market Share by Disease/Disorders (%), 2018-2027 9.2 Gene Editing Technology Market Size and Forecast by Cancer, 2018-2027 9.3 Gene Editing Technology Market Size and Forecast by Blood Disorders, 2018-2027 9.4 Gene Editing Technology Market Size and Forecast by Blindness, 2018-2027 9.5 Gene Editing Technology Market Size and Forecast by Respiratory Disease, 2018-2027 9.6 Gene Editing Technology Market Size and Forecast by Others, 2018-2027 10 Gene Editing Technology Market Size by Application, 2018-2027 10.1 Gene Editing Technology Market Share by Application (%), 2018-2027 10.2 Gene Editing Technology Market Size and Forecast by Drug Development, 2018-2027 10.3 Gene Editing Technology Market Size and Forecast by Diagnostics, 2018-2027 10.4 Gene Editing Technology Market Size and Forecast by Plant Gene Editing, 2018-2027 10.5 Gene Editing Technology Market Size and Forecast by Animal Gene Editing, 2018-2027 11 Gene Editing Technology Market Size by End Users, 2018-2027 11.1 Gene Editing Technology Market Share by End User (%), 2018-2027 11.2 Gene Editing Technology Market Size and Forecast by Pharmaceutical and Biopharmaceutical Companies, 2018-2027 11.3 Gene Editing Technology Market Size and Forecast by Biotechnology Companies, 2018-2027 11.4 Gene Editing Technology Market Size and Forecast by Contract Research Organisations, 2018-2027 11.5 Gene Editing Technology Market Size and Forecast by Academic Institutes and Research Centres, 2018-2027 12 Further Reading 12.1 About BioIntel360 12.2 Related Research 12.3 Consulting
Table 1: Gene Editing Technology Market Size by Value (USD Million), 2018-2027 Table 2: Gene Editing Technology Market Size by CRISPR by Value (USD Million), 2018-2027 Table 3: Gene Editing Technology Market Size by TALENs by Value (USD Million), 2018-2027 Table 4: Gene Editing Technology Market Size by ZFNs by Value (USD Million), 2018-2027 Table 5: Gene Editing Technology Market Size by Meganucleases by Value (USD Million), 2018-2027 Table 6: Gene Editing Technology Market Size by Vector Based Cas9 by Value (USD Million), 2018-2027 Table 7: Gene Editing Technology Market Size by DNA Free Cas9 by Value (USD Million), 2018-2027 Table 8: Gene Editing Technology Market Size by Libraries & Antibodies by Value (USD Million), 2018-2027 Table 9: Gene Editing Technology Market Size by gRNA Design and Vector Construction by Value (USD Million), 2018-2027 Table 10: Gene Editing Technology Market Size by Cell Lines & Engineering (USD Million), 2018-2027 Table 11: Gene Editing Technology Market Size by Others (Plasmid, Controls) (USD Million), 2018-2027 Table 12: Gene Editing Technology Market Size by Kits & Enzymes (USD Million), 2018-2027 Table 13: Gene Editing Technology Market Size by Cell lines & Antibodies (USD Million), 2018-2027 Table 14: Gene Editing Technology Market Size by Others (Plasmid, Controls) (USD Million), 2018-2027 Table 15: Gene Editing Technology Market Size by Kits & Enzymes (USD Million), 2018-2027 Table 16: Gene Editing Technology Market Size by Cell lines & Antibodies (USD Million), 2018-2027 Table 17: Gene Editing Technology Market Size by Others (Plasmid, Controls) (USD Million), 2018-2027 Table 18: Gene Editing Technology Market Size by Kits & Enzymes (USD Million), 2018-2027 Table 19: Gene Editing Technology Market Size by Cell lines & Antibodies (USD Million), 2018-2027 Table 20: Gene Editing Technology Market Size by Others (Plasmid, Controls) (USD Million), 2018-2027 Table 21: Gene Editing Technology Market Size by Ex-vivo (USD Million), 2018-2027 Table 22: Gene Editing Technology Market Size by In-vivo (USD Million), 2018-2027 Table 23: Gene Editing Technology Market Size by Cancer by Value (USD Million), 2018-2027 Table 24: Gene Editing Technology Market Size by Blood Disorders by Value (USD Million), 2018-2027 Table 25: Gene Editing Technology Market Size by Blindness by Value (USD Million), 2018-2027 Table 26: Gene Editing Technology Market Size by Respiratory Disease by Value (USD Million), 2018-2027 Table 27: Gene Editing Technology Market Size by Others (USD Million), 2018-2027 Table 28: Gene Editing Technology Market Size by Drug Development by Value (USD Million), 2018-2027 Table 29: Gene Editing Technology Market Size by Diagnostics by Value (USD Million), 2018-2027 Table 30: Gene Editing Technology Market Size by Plant Gene Editing by Value (USD Million), 2018-2027 Table 31: Gene Editing Technology Market Size by Animal Gene Editing by Value (USD Million), 2018-2027 Table 32: Gene Editing Technology Market Size by Pharmaceutical and Biopharmaceutical Companies by Value (USD Million), 2018-2027 Table 33: Gene Editing Technology Market Size by Biotechnology Companies by Value (USD Million), 2018-2027 Table 34: Gene Editing Technology Market Size by Contract Research Organisations by Value (USD Million), 2018-2027 Table 35: Gene Editing Technology Market Size by Academic Institutes and Research Centres by Value (USD Million), 2018-2027
Figure 1: Gene Editing Technology Market Size by Value (USD Million), 2018-2027 Figure 2: Gene Editing Technology Market Share by Technology (%), 2018-2027 Figure 3: Gene Editing Technology Market Size by CRISPR by Value (USD Million), 2018-2027 Figure 4: Gene Editing Technology Market Size by TALENs by Value (USD Million), 2018-2027 Figure 5: Gene Editing Technology Market Size by ZFNs by Value (USD Million), 2018-2027 Figure 6: Gene Editing Technology Market Size by Meganucleases by Value (USD Million), 2018-2027 Figure 7: Gene Editing Technology Market Share by CRISPR Product (%), 2018-2027 Figure 8: Gene Editing Technology Market Size by Vector Based Cas9 by Value (USD Million), 2018-2027 Figure 9: Gene Editing Technology Market Size by DNA Free Cas9 by Value (USD Million), 2018-2027 Figure 10: Gene Editing Technology Market Size by Libraries & Antibodies by Value (USD Million), 2018-2027 Figure 11: Gene Editing Technology Market Size by gRNA Design and Vector Construction by Value (USD Million), 2018-2027 Figure 12: Gene Editing Technology Market Size by Cell Lines & Engineering by Value (USD Million), 2018-2027 Figure 13: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027 Figure 14: Gene Editing Technology Market Share by TALENs Product (%), 2018-2027 Figure 15: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027 Figure 16: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027 Figure 17: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027 Figure 18: Gene Editing Technology Market Share by ZFNs Product (%), 2018-2027 Figure 19: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027 Figure 20: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027 Figure 21: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027 Figure 22: Gene Editing Technology Market Share by Meganucleases Product (%), 2018-2027 Figure 23: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027 Figure 24: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027 Figure 25: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027 Figure 26: Gene Editing Technology Market Share, By Delivery Mode, 2018-2027 Figure 27: Gene Editing Technology Market Size by Ex-vivo by Value (USD Million), 2018-2027 Figure 28: Gene Editing Technology Market Size by In-vivo by Value (USD Million), 2018-2027 Figure 29: Gene Editing Technology Market Share by Diseases/Disorders (%), 2018-2027 Figure 30: Gene Editing Technology Market Size by Cancer by Value (USD Million), 2018-2027 Figure 31: Gene Editing Technology Market Size by Blood Disorders by Value (USD Million), 2018-2027 Figure 32: Gene Editing Technology Market Size by Blindness by Value (USD Million), 2018-2027 Figure 33: Gene Editing Technology Market Size by Respiratory Disease by Value (USD Million), 2018-2027 Figure 34: Gene Editing Technology Market Size by Others by Value (USD Million), 2018-2027 Figure 35: Gene Editing Technology Market Share by Applications (%), 2018-2027 Figure 36: Gene Editing Technology Market Size by Drug Development by Value (USD Million), 2018-2027 Figure 37: Gene Editing Technology Market Size by Diagnostics by Value (USD Million), 2018-2027 Figure 38: Gene Editing Technology Market Size by Plant Gene Editing by Value (USD Million), 2018-2027 Figure 39: Gene Editing Technology Market Size by Animal Gene Editing by Value (USD Million), 2018-2027 Figure 40: Gene Editing Technology Market Share by End Users (%), 2018-2027 Figure 41: Gene Editing Technology Market Size by Pharmaceutical and Biopharmaceutical Companies by Value (USD Million), 2018-2027 Figure 42: Gene Editing Technology Market Size by Biotechnology Companies by Value (USD Million), 2018-2027 Figure 43: Gene Editing Technology Market Size by Contract Research Organisations by Value (USD Million), 2018-2027 Figure 44: Gene Editing Technology Market Size by Academic Institutes and Research Centres by Value (USD Million), 2018-2027
